We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Objective Systolic Function Recuperation Assessed by Echocardiography (ROSE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01086124
First Posted: March 12, 2010
Last Update Posted: July 8, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Paul Farand, Universitaire de Sherbrooke
  Purpose
The purpose of this study is to evaluate left ventricular systolic ejection fraction and anterior or apical akinesis 1 month and 3 months after a myocardial infarction treated with primary PCI to determine whether improvement at 1 month differs from improvement at 3 months.

Condition
Myocardial Infarction Left Ventricular Systolic Dysfunction Anterior Akinesis Apical Akinesis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Objective Systolic Function Recuperation Assessed by Echocardiography

Resource links provided by NLM:


Further study details as provided by Paul Farand, Universitaire de Sherbrooke:

Primary Outcome Measures:
  • Left ventricular ejection fraction recuperation 1 month post myocardial infarction [ Time Frame: 1 month post myocardial infarction ]
    Left ventricular ejection fraction recuperation 1 month post myocardial infarction as compared with the left ejection fraction 3 months post myocardial infarction


Secondary Outcome Measures:
  • Anterior and apical akinesis recuperation 1 month post myocardial infarction [ Time Frame: 1 month post myocardial infarction ]
    Anterior and apical akinesis recuperation 1 month post myocardial infarction as compared with 3 months post myocardial infarction


Enrollment: 42
Study Start Date: March 2010
Study Completion Date: December 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Echocardiography 1 month
Patients will all have an echocardiography 1 month post myocardial infarction and 3 months post myocardial infarction

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients presenting to teaching hospital or sent from community hopitals to teaching hospital for primary PCI
Criteria

Inclusion Criteria:

  • Older than 18 years old
  • ST elevation myocardial infarction treated with primary PCI
  • Anterior or apical akinesis and left ventricular ejection fraction ≤ 45% on early echocardiography (48hours - 7 days post myocardial infarction)
  • Initial ECG showing at least 1 mm ST elevation in 2 leads corresponding to the same vascular territory

Exclusion Criteria:

  • Known left ventricular systolic dysfunction before myocardial infarction
  • Left bundle branch block
  • Vital prognosis less than 6 months
  • Cardiogenic shock
  • Rescue PCI
  • Sub-optimal echocardiographic imaging (contrast use is allowed)
  • Significant valvular heart disease (moderate or severe)
  • Surgical revascularization
  • Pregnancy or breastfeeding
  • Incapacity to provide informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01086124


Locations
Canada, Quebec
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4
Sponsors and Collaborators
Paul Farand
Investigators
Principal Investigator: Paul Farand, md Centre de recherche du Centre hospitalier universitaire de Sherbrooke
  More Information

Responsible Party: Paul Farand, MD, Universitaire de Sherbrooke
ClinicalTrials.gov Identifier: NCT01086124     History of Changes
Other Study ID Numbers: 10-010
First Submitted: March 11, 2010
First Posted: March 12, 2010
Last Update Posted: July 8, 2013
Last Verified: July 2013

Keywords provided by Paul Farand, Universitaire de Sherbrooke:
echocardiography
ST elevation myocardial infarction
Heart failure
Coronary artery disease
Cardiovascular diseases

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ventricular Dysfunction, Left
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Ventricular Dysfunction